- Education
-
Research
- Research Offices
- Office for Research
- Office of Grants and Contracts
- Clinical Trials Office
- Graduate Programs Office
- Health Sciences Library
- Research Faculty Directory
- Resources for
- New Faculty
- Administrators
- Graduate Students/Postdocs
- Medical Students
-
Patient Care
- School of Medicine
- Patient Care Mission
- Available Clinical Trials
- Health System
- Find a Physician
- Make an Appointment
- Health System Home
-
Community Service
-
Clinical Departments
- Departments
- Anesthesiology
- Dentistry
- Department of Medicine
- Dermatology
- Emergency Medicine
- Family Medicine
- Family Medicine
- Neurological Surgery
- Neurology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Otolaryngology
- Pathology
- Pediatrics
- Physical Medicine & Rehabilitation
- Plastic & Maxillofacial Surgery
- Basic Science Departments
-
Administration
- Education Offices
- Admissions Office
- Financial Aid Office
- Medical Education
- Curriculum
- Faculty/Staff
- Faculty Development
- Administrator Development
- Faculty Policies
- Finance & Human Resources
- School Administration
- Office of Administration
- Departmental Contacts
- Center Contacts
- SOM Factbook
- About the School
Rebecca Dillingham, M.D.
Dr. Rebecca Dillingham is Associate Director of the Center. She is also an assistant professor of research and medicine in the Department of Medicine in the Division of Infectious Diseases and International Health at the University of Virginia Medical School.
Training
Dr. Dillingham majored in history and science at Harvard College. She received her medical degree from the University of Missouri. She completed her internship and residency in internal medicine at the University of Virginia before serving as a fellow in the Division of Infectious Diseases and International Health.
Research Interests
Dr. Dillingham's research interests are HIV medicine in resource-limited settings, including Haiti, and global health education
Publications
Dr. Dillingham has written recently about the outcomes of patients on antiretrovial therapy in poor countries.